CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 100 filers reported holding CULLINAN ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,564,915 | -26.7% | 283,416 | -12.8% | 0.00% | – |
| Q2 2023 | $3,497,936 | +106.0% | 325,087 | +95.9% | 0.00% | – |
| Q1 2023 | $1,697,648 | -28.5% | 165,948 | -26.3% | 0.00% | – |
| Q4 2022 | $2,373,940 | -35.8% | 225,018 | -21.9% | 0.00% | -100.0% |
| Q3 2022 | $3,696,000 | -16.6% | 288,280 | -16.6% | 0.00% | 0.0% |
| Q2 2022 | $4,430,000 | -15.0% | 345,543 | -30.6% | 0.00% | 0.0% |
| Q1 2022 | $5,213,000 | +2.5% | 497,875 | +51.1% | 0.00% | 0.0% |
| Q4 2021 | $5,084,000 | +217.9% | 329,456 | +365.3% | 0.00% | – |
| Q3 2021 | $1,599,000 | -6.4% | 70,799 | +6.7% | 0.00% | – |
| Q2 2021 | $1,709,000 | +10581.2% | 66,349 | +17133.5% | 0.00% | – |
| Q1 2021 | $16,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |